Document is current
Any future updates will be listed below
-
Authors
Cadiz, Mika P.
Jensen, Tanner D.
Sens, Jonathon P.
Zhu, Kuixi
Song, Won-Min
Zhang, Bin
Ebbert, Mark
Chang, Rui
Fryer, John D. http://orcid.org/0000-0003-3390-2994
-
Funding
Funding for this research was provided by:
Mayo Foundation for Medical Education and Research
Ben Dov Family Luminescence Foundation
Ed and Ethel Moore Alzheimer’s Disease Research Program of Florida Department of Health (6AZ06)
Coins for Alzheimer's Research Trust
CureAlz Foundation
JW and HM Goodman Family Foundation
National Institutes of Health (NS084974, AG062556, AG062110, NS094137, AG057997, AG062077, NS110435, AG047327, AG049992, AG057457, AG062620, AG057931, AG059093, AG046170, AG068030)
- License Information
-
More Information
Article History
Received: 25 August 2021
Accepted: 9 March 2022
First Online: 28 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: RC is founder of INTelico Therapeutics LLC, AZ, 85718, USA, a company focused on drug target discovery and precision therapeutics based upon probabilistic models of disease. This study is not supported by any funding from INTelico Therapeutics LLC.
